-+ 0.00%
-+ 0.00%
-+ 0.00%

AKEBIA THERAPEUTICS ANNOUNCES POSITIVE OPINION OF EUROPEAN MEDICINES AGENCY FOR XOANACYL®, AN ORAL THERAPY FOR CHRONIC KIDNEY DISEASE LICENSED TO AVEROA

Reuters·04/03/2025 12:02:58

Please log in to view news